Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

New Philips platform offers AI-powered ECG tools from outside vendors

Philips Healthcare launched the Philips ECG AI Marketplace platform that gives cardiac care teams access to multiple vendor offerings in one central location to more efficiently manage and implement artificial intelligence (AI)-powered diagnostic tools through Philips ECG workstations.

Philips has launched a new 'AI Marketplace' that expands access to third-party diagnostic tools. The company's goal is to put a variety of offerings into one convenient location for clinicians.

  • Read more about New Philips platform offers AI-powered ECG tools from outside vendors

The power of prevention: Cardiologist says proactive patient care can make a big difference later in life

Former American College of Cardiology (ACC) president Kim Allan Williams, Sr., MD, MACC, MASNC, FAHA, FESC, chair, department of medicine, University of Louisville School of Medicine, and an ACC delegate to the American Medical Association House of Delegates, discusses how cardiology should be focusing more on earlier prevention efforts in cardiology.

Former ACC president Kim Allan Williams Sr., MD, thinks cardiologists should be much more proactive. Encouraging healthy eating habits now, for example, can keep patients out of the hospital later in life and reduce healthcare spending.

  • Read more about The power of prevention: Cardiologist says proactive patient care can make a big difference later in life

Use of imaging guidance during coronary interventions has doubled in recent years

Interventional cardiologists performing PCI

Photo courtesy of Jose Arellano.

New research, published in The American Journal of Cardiology, uncovers widespread variability in provider preference for image guidance during PCI. 

  • Read more about Use of imaging guidance during coronary interventions has doubled in recent years

New ASE president outlines key initiatives in cardiac ultrasound

American Society of Echocardiography President David Wiener, MD, FASE, outlined is initiatives for the next year, calling for wider collaboration, sustaining the workforce and better engagement with members.

American Society of Echocardiography President David H. Wiener, MD, said one of his biggest goals is to help the group thrive in the face of ongoing workforce challenges. He also hopes to get new members involved.

  • Read more about New ASE president outlines key initiatives in cardiac ultrasound

Medtronic expands peripheral portfolio with new distribution deal

healthcare business deal

The company has finalized an exclusive distribution deal with Future Medical Design to sell its stainless steel peripheral guidewires in the United States. 

  • Read more about Medtronic expands peripheral portfolio with new distribution deal

FDA clears AI-powered software for real-time TAVR guidance

Caranx Medical TAVIPILOT

Caranx Medical is focused on using AI, robotics and other advanced technologies to expand patient access to life-saving procedures. This new software, for example, helps guide cardiologists through complex TAVR procedures.

  • Read more about FDA clears AI-powered software for real-time TAVR guidance

ASNC lobbies Congress to curb prior authorization, oppose AUC mandates and embrace payment reform

Suman Tandon, MD, FASNC, a cardiac imager at St. Francis Hospital and Heart Center, in Rosyln, New York, and an American Society of Nuclear Cardiology (ASNC) representative to the American Medical Association (AMA) House of Delegates (HOD), explains ASNC’s call on Congress for to reduce prior authorization, appropriate use mandates and to make Medicare payment reforms.

Suman Tandon, MD, an American Society of Nuclear Cardiology board member, explains the group's call on Congress to update a number of healthcare policies. 

  • Read more about ASNC lobbies Congress to curb prior authorization, oppose AUC mandates and embrace payment reform

CMS proposal includes cardiologist pay bump—cuts to high-value services still a concern

Among general cardiologists, for example, median compensation jumped nearly 8% from 2023 to 2024. Interventional cardiology and electrophysiology saw even larger jumps. Dollar money graphic showing increased finance.

The 2026 MPFS proposed rule includes higher conversion factors across the board. However, some cardiology groups remain concerned about a series of reimbursement reductions for high-value cardiology services. 

  • Read more about CMS proposal includes cardiologist pay bump—cuts to high-value services still a concern

Yes, researchers argue, vitamin D supplements help protect the heart

vitamin d supplement heart health CVD

The ongoing debate continues. The team behind this latest analysis pointed to more than 40 years of research to make its point.

  • Read more about Yes, researchers argue, vitamin D supplements help protect the heart

Update to Johnson & Johnson PFA platform gains FDA approval

The late-breaking U.S. multicenter admIRE clinical trial at the Heart Rhythm Society 2024 meeting, showed positive data on the long-term safety and effectiveness of the the Biosense Webster Varipulse pulsed field ablation (PFA) system in patients with paroxysmal atrial fibrillation. #HRS #HRS2024 #PFA

Johnson & Johnson MedTech's Varipulse PFA catheter. Image courtesy of Johnson & Johnson MedTech.

The Varipulse PFA platform originally gained FDA approval in 2024. According to Johnson & Johnson MedTech, this update was put in place to help the technology provide better patient outcomes going forward.

  • Read more about Update to Johnson & Johnson PFA platform gains FDA approval

Pagination

    • First page « First
    • Previous page ‹ Previous
    • Page …119
    • Page 120
    • Page 121
    • Page 122
    • Current page 123
    • Page 124
    • Page 125
    • Page 126
    • Page 127 …
    • Next page Next ›
    • Last page Last »
Subscribe
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme